BioSpace News Archive

The stocks of approximately 10,000 companies are traded daily in the multi-tiered OTC Markets, but only companies in the top tier qualify to trade on the OTCQX. T

Stallergenes Greer announced that its partner in Japan, Shionogi & Co. Ltd., received approval for the extension of the indication for ACTAIR, an allergy immunotherapy sublingual tablet for the treatment of house dust mite (HDM) induced allergic rhinitis.

The manuscript of Dr. Lyne Gagnon et al. examines PBI-4050’s ligand affinity in vitro and in vivo for the fatty acid receptors, GPR40 and GPR84.

Origin Agritech Limited today announced the Board of Directors has appointed Dr. Z. James Chen to be the Chief Executive Officer effective on March 1, 2018.

These measures were taken due to the Company not meeting the continued listing requirements of the TSX.

The implantation was facilitated by the Company’s exclusive distribution partner in Singapore, Mandarin Opto-Medic Co Pte Ltd.

The study evaluated 2,189 cases that spanned 26 cancer types, of which 1,108 were colorectal cancer, to compare mismatch repair status of Caris’ NGS platform to the current industry standard of PCR-FA.

Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new red InGenius3 gel documentation system. Designed with a small darkroom which scientists can use with a choice of UV, blue and white lighting, the InGenius3 is excellent for laboratories looking for a versatile, budget system to accurately image both DNA and protein

Castle Biosciences announced the presentation of a study highlighting research on a new clinical use for the DecisionDx-Melanoma gene expression profile test to guide sentinel lymph node biopsy (SLNB) recommendations.

The Note matures on February 28, 2021 and will be convertible, at the option of the holder, into common shares in the capital of the Company at a price per Common Share of $0.60.